LANXESS

LANXESS

Develops and manufactures chemical intermediates, additives and consumer protection products.

Launch date
Employees
Market cap
CAD3.2b
Enterprise valuation
CAD6.9b (Public information from Sep 2024)
Cologne Nordrhein-Westfalen (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2020202120222023202420252026
Revenues6.1b7.6b8.1b6.7b6.5b6.8b7.1b
% growth(10 %)24 %7 %(17 %)(3 %)5 %4 %
EBITDA1.8b1.0b1.0b763m587m731m828m
% EBITDA margin30 %14 %13 %11 %9 %11 %12 %
Profit885m267m250m443m(193m)(6.8m)94.8m
% profit margin14 %4 %3 %7 %(3 %)-1 %
EV / revenue1.1x0.9x0.9x0.7x0.7x0.7x0.6x
EV / EBITDA3.5x6.6x6.8x6.5x8.1x6.3x5.3x
R&D budget108m115m102m99.0m---
R&D % of revenue2 %2 %1 %1 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
N/A

€1.1m

Grant
Total FundingCAD1.7m

Recent News about LANXESS

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
  • Edit
Gevo
exited
Unitex Chemical
ACQUISITION by LANXESS Oct 2011
Arlanxeo
ACQUISITION by Saudi Aramco Aug 2018
Emerald Kalama Chemical
ACQUISITION by LANXESS Feb 2021
INTACE
ACQUISITION by LANXESS Mar 2021
Theseo
ACQUISITION by LANXESS Apr 2021